NCT05522387 2026-02-27An Open-Label Extension of XPro1595 in Patients With Alzheimer's DiseaseInmune Bio, Inc.Phase 2 Terminated11 enrolled
NCT05049148 2026-01-05PlatonFondation Ophtalmologique Adolphe de RothschildPhase NA Recruiting50 enrolled
NCT06887673 2025-03-20Lipid Mediators & Cancer: Montelukast, SPM, and AlmondsUniversity of South FloridaPhase EARLY_PHASE1 Not yet recruiting56 enrolled
NCT05321498 2023-09-28Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of InflammationInmune Bio, Inc.Phase 2 Withdrawn